SZSE:002437 (China)
Â
Class A
Â¥
2.09
(+1.95%)
Apr 26
Business Description
Harbin Gloria Pharmaceuticals Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000QG8
Share Class Description:
SZSE:002437: Class ACompare
Compare
Traded in other countries / regions
002437.China IPO Date
2010-06-23Description
Harbin Gloria Pharmaceuticals Co Ltd is a tech biopharmaceutical enterprise. It is engaged in the research, development, production, and sale of pharmaceutical products primarily in China. The company offers cardiovascular drugs; cardiac cerebrovascular medication; vitamins and minerals; urinary tract drugs; urinary system medication; anti-tumor medication; endocrine system drugs; anti-infective drugs; digestive system medication; respiratory medication; and other medications.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.05 | |||||
| Equity-to-Asset | 0.53 | |||||
| Debt-to-Equity | 0.41 | |||||
| Debt-to-EBITDA | 3.08 | |||||
| Interest Coverage | 5.77 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.5 | |||||
| Beneish M-Score | -2.74 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -4.9 | |||||
| 3-Year EBITDA Growth Rate | -26.2 | |||||
| 3-Year Book Growth Rate | -3.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.49 | |||||
| 9-Day RSI | 55.42 | |||||
| 14-Day RSI | 51.37 | |||||
| 6-1 Month Momentum % | -4.07 | |||||
| 12-1 Month Momentum % | -5.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.82 | |||||
| Quick Ratio | 0.68 | |||||
| Cash Ratio | 0.5 | |||||
| Days Inventory | 68.94 | |||||
| Days Sales Outstanding | 28.72 | |||||
| Days Payable | 25.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 12.18 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 58.39 | |||||
| Operating Margin % | 9.37 | |||||
| Net Margin % | 4.58 | |||||
| FCF Margin % | 9.31 | |||||
| ROE % | 7.17 | |||||
| ROA % | 3.28 | |||||
| ROIC % | 5.51 | |||||
| ROC (Joel Greenblatt) % | 20.09 | |||||
| ROCE % | 12.37 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.45 | |||||
| PE Ratio without NRI | 33.77 | |||||
| Shiller PE Ratio | 324.76 | |||||
| Price-to-Owner-Earnings | 55.68 | |||||
| PS Ratio | 1.73 | |||||
| PB Ratio | 2.72 | |||||
| Price-to-Tangible-Book | 4.18 | |||||
| Price-to-Free-Cash-Flow | 18.39 | |||||
| Price-to-Operating-Cash-Flow | 16.48 | |||||
| EV-to-EBIT | 21.05 | |||||
| EV-to-EBITDA | 21.05 | |||||
| EV-to-Revenue | 1.76 | |||||
| EV-to-FCF | 18.89 | |||||
| Price-to-Projected-FCF | 0.91 | |||||
| Price-to-Median-PS-Value | 0.86 | |||||
| Price-to-Graham-Number | 2.52 | |||||
| Earnings Yield (Greenblatt) % | 4.75 | |||||
| FCF Yield % | 5.23 | |||||
| Forward Rate of Return (Yacktman) % | 0.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Harbin Gloria Pharmaceuticals Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,626.039 | ||
| EPS (TTM) (Â¥) | 0.055 | ||
| Beta | 0.78 | ||
| Volatility % | 39.72 | ||
| 14-Day RSI | 51.37 | ||
| 14-Day ATR (Â¥) | 0.068289 | ||
| 20-Day SMA (Â¥) | 2.076 | ||
| 12-1 Month Momentum % | -5.78 | ||
| 52-Week Range (Â¥) | 1.67 - 3.15 | ||
| Shares Outstanding (Mil) | 2,270.51 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Harbin Gloria Pharmaceuticals Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Harbin Gloria Pharmaceuticals Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Harbin Gloria Pharmaceuticals Co Ltd Frequently Asked Questions
What is Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437)'s stock price today?
The current price of SZSE:002437 is ¥2.09. The 52 week high of SZSE:002437 is ¥3.15 and 52 week low is ¥1.67.
When is next earnings date of Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437)?
The next earnings date of Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) is .
Does Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) pay dividends? If so, how much?
Harbin Gloria Pharmaceuticals Co Ltd(SZSE:002437) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers